What is Global Anti-inflammatory Therapeutics Market?
The Global Anti-inflammatory Therapeutics Market is a vast and dynamic sector that focuses on the development and distribution of treatments aimed at reducing inflammation in the body. These treatments are crucial in managing a variety of diseases that are characterized by excessive inflammation, such as arthritis, respiratory diseases, and certain skin and gastrointestinal conditions. The market is composed of various types of anti-inflammatory therapeutics, including Anti-inflammatory Biologics, Non-Steroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids, and others. Each of these categories has its unique properties and applications, making them indispensable in the healthcare industry.

Anti-inflammatory Biologics, Non-Steroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids, Others in the Global Anti-inflammatory Therapeutics Market:
Anti-inflammatory Biologics are a type of drug that is derived from living organisms. These drugs are used to treat a variety of conditions, including autoimmune diseases like rheumatoid arthritis and psoriasis. Non-Steroidal Anti-inflammatory Drugs (NSAIDs) are a class of drugs that reduce pain, decrease fever, prevent blood clots, and in higher doses, decrease inflammation. Corticosteroids are a class of drug that lowers inflammation in the body. They also reduce immune system activity. These drugs are used to treat a variety of conditions, including asthma, allergies, arthritis, and skin conditions. Other types of anti-inflammatory therapeutics include various natural and synthetic compounds that have anti-inflammatory properties.
Arthritis, Respiratory Diseases, Dermatology, Gastroenterology, Others in the Global Anti-inflammatory Therapeutics Market:
The Global Anti-inflammatory Therapeutics Market plays a crucial role in the treatment of various diseases. For instance, in the field of Arthritis, these therapeutics are used to manage the chronic inflammation that characterizes this condition, thereby alleviating pain and preventing further joint damage. In Respiratory Diseases, anti-inflammatory therapeutics are used to reduce the inflammation in the airways that leads to symptoms like coughing, wheezing, and shortness of breath. In Dermatology, these drugs are used to treat a variety of skin conditions that are characterized by inflammation, such as psoriasis and eczema. In Gastroenterology, anti-inflammatory therapeutics are used to manage conditions like inflammatory bowel disease, which involves chronic inflammation of the digestive tract. Other areas where these therapeutics are used include the treatment of allergies, autoimmune diseases, and certain types of cancer.
Global Anti-inflammatory Therapeutics Market Outlook:
The Global Anti-inflammatory Therapeutics Market has shown significant growth in recent years. In 2022, the market was valued at US$ 117860 million. This value is expected to increase to US$ 168130 million by 2029, indicating a Compound Annual Growth Rate (CAGR) of 6.1% during the forecast period of 2023-2029. This growth can be attributed to various factors, including the increasing prevalence of inflammatory diseases, advancements in biologic therapies, and the growing awareness about the importance of early diagnosis and treatment. In 2019, AbbVie, a leading biopharmaceutical company, maintained its top position in the market, accounting for a 21.59% market share. Other key players in the market include Johnson & Johnson, Amgen Inc, and AstraZeneca PLC, which accounted for 14.20%, 5.43%, and 5.32% of the market share respectively.
Report Metric | Details |
Report Name | Anti-inflammatory Therapeutics Market |
Accounted market size in 2022 | US$ 117860 million |
Forecasted market size in 2029 | US$ 168130 million |
CAGR | 6.1% |
Base Year | 2022 |
Forecasted years | 2023 - 2029 |
Segment by Type |
|
Segment by Application |
|
By Region |
|
By Company | AbbVie, Johnson & Johnson, Amgen Inc, AstraZeneca PLC, Pfizer, Inc, Novartis, Roche, Merck, Sanofi, GlaxoSmithKline, Sun Pharmaceutical Industries Ltd, TEVA |
Forecast units | USD million in value |
Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |